Orion OYJ (OTCMKTS:ORINY) Posts Quarterly Earnings Results

Orion OYJ (OTCMKTS:ORINY) announced its earnings results on Thursday. The company reported $1.08 earnings per share for the quarter, Zacks reports. Orion OYJ had a return on equity of 51.23% and a net margin of 26.68%.The company had revenue of $809.41 million during the quarter.

Orion OYJ Stock Performance

Orion OYJ stock opened at $39.73 on Friday. Orion OYJ has a 1 year low of $25.95 and a 1 year high of $42.75. The company’s 50-day moving average is $37.53 and its two-hundred day moving average is $37.60. The company has a current ratio of 1.99, a quick ratio of 1.19 and a debt-to-equity ratio of 0.13. The company has a market cap of $11.21 billion, a PE ratio of 19.47 and a beta of 0.04.

Analyst Upgrades and Downgrades

Separately, Danske lowered shares of Orion OYJ from a “buy” rating to a “hold” rating in a report on Thursday, January 15th. One investment analyst has rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat.com, Orion OYJ currently has an average rating of “Hold”.

About Orion OYJ

Orion Corporation (Orion Oyj) is a Finland-based pharmaceutical company engaged in the research, development, manufacture and marketing of human and veterinary medicines as well as diagnostic tests. The company’s core therapeutic areas include central nervous system disorders, oncology and respiratory diseases, and it offers both proprietary and generic products. Orion’s product range spans from small-molecule drugs and active pharmaceutical ingredients to radiodiagnostic imaging agents and line extensions developed through in-house research.

Since its founding in 1917 in Helsinki, Orion has grown into an integrated pharmaceuticals business with state-of-the-art manufacturing facilities in Finland and France.